Produkty 1852-43-3

CAS 1852-43-3 występuje w naszej ofercie pod nazwami: Androsterone beta-D-Glucuronide, >95% (HPLC), Androsterone b-D-Glucuronide, >95% (HPLC), Androsterone glucuronide, 95.10%. Oferty producentów: TRC, MedChemExpress. Dostępne opakowania: 2,5mg, 25mg, 2.5 mg.

Androsterone beta-D-Glucuronide, >95% (HPLC)
TRC
  • opakowanie: 2,5mg
  • Warianty: 1
Zobacz produkt
Androsterone b-D-Glucuronide, >95% (HPLC)
TRC
  • opakowanie: 25mg
  • Warianty: 1
Zobacz produkt
Androsterone glucuronide, 95.10%
MedChemExpress
  • opakowanie: 2.5 mg
  • Warianty: 1
od 2474,51
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3S,4S,5R,6R)-6-[[(3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid (CAS 1852-43-3) to związek chemiczny o wzorze sumarycznym C25H38O8 i masie molowej 466.6 g/mol. Nazwa systematyczna IUPAC: (2S,3S,4S,5R,6R)-6-[[(3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid. InChIKey: VFUIRAVTUVCQTF-BSOWLZGZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC25H38O8
Masa molowa466.6 g/mol
Nazwa IUPAC(2S,3S,4S,5R,6R)-6-[[(3R,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
InChIKeyVFUIRAVTUVCQTF-BSOWLZGZSA-N
SMILESC[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Androsterone glucuronide, Androsterone 3-glucuronide, Androsterone glucosiduronate, androsterone 3-glucosiduronic acid, 3alpha-hydroxy-5alpha-androstan-17-one 3-D-glucuronide, 3alpha-hydroxy-5alpha-androstan-17-one glucuronide, (3alpha,5alpha)-17-oxoandrostan-3-yl beta-D-glucopyranosiduronic acid, beta-D-Glucopyranosiduronic acid, (3alpha,5alpha)-17-oxoandrostan-3-yl, Androsterone-G, ADT-G
Powiązane formy tego związku
(2S,3S,4S,5R,6R)-6-[[(3S,5S,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C25H38O8
(2S,3S,4S,5R,6R)-6-[[(3R,5R,8R,9S,10S,13S,14S)-10,13-dimethyl-17-oxo-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C25H38O8
(2S,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[[(3R,5R,8R,9S,10S,13S,14S)-2,2,3,4,4-pentadeuterio-10,13-dimethyl-17-oxo-5,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-2-carboxylic acid C25H38O8
Izomery (ten sam wzór sumaryczny)
(2S,3S,4S,5R,6R)-6-[[(5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C25H38O8